OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2023-03-31-accounts

Stem cell and bone marrow transplants are now regularly used as curative treatments for patients with blood cancer (such as lymphoma, myeloma and leukaemia). Yet 4 in 5 patients from black, Asian, mixed-heritage or other minority ethnic groups are unable to find a donor match.

Race Against Blood Cancer works to increase the total number of people on the stem cell and bone marrow register, with a particular emphasis on increasing the level of sign up from minority groups – whether defined by race, ethnicity or gender – who are vastly underrepresented on the donor registry at present. Our vision is that one day, all blood cancer patients will have the equal opportunity of a quality stem cell match.

We have a simple overarching strategy to deliver on our vision:

  1. Raise awareness of the underrepresentation issue and improve apathy;

  2. Educate people on the process of becoming a donor and demystifying the many myths that currently exist; and

  3. Help simplify the donor sign up process, making it more accessible for everyone.

The Trustees of Race Against Blood Cancer are pleased to present our Annual Report which covers the financial year 1st April 2022 to 31st March 2023. Having seen the challenges for previous reporting periods prove more difficult due to the post-pandemic recovery and the cost of living crisis, 2023 has seen an increase in activity such as our in-person donor drives and supporter driven events. However, we are reeling from the significant impact with lack of funding.

As a result of our efforts in previous years, some of our potential stem cell donors continued to be matched to patients in need, with the charity responsible for stem cell transplants from the pool of over 10,000 donors that we have recruited.

Employees

General Manager Nicola Martenstyn

Nicola (part-time) is supported by the Community Engagement Manager (full time) Gemma Elsmore (West Midlands).

Both the General Manager and Community Engagement Manager roles have been made possible by receiving appropriate funding and they will continue to work towards increasing donor recruitment activities as a priority for re-establishing our engagement and growth. Additional funding has been secured so that these roles will continue until the end of this financial year (2023/24).

In addition to our paid staff, we are ably supported by a number of volunteers who assist with our finance administration and donor recruitment events. Our grateful thanks must go to this group for their commitment to the charity; they are instrumental to our current and future success and have remained steadfast in terms of their support.

We are also developing a new volunteering scheme called ‘RABC Champs’ which will specifically engage with and recruit young people. The vision for this will be to support such volunteers to help us raise awareness and to sign-up peers to the donor register.

Achievements and performance

Donor recruitment

All face to face donor recruitment events have returned to what they were prior to the pandemic (in terms of level of activity and engagement). With our Community Engagement Manager in place, our aim is to engage with the general public in a face-to-face capacity in order to recruit new people onto the donor register. We have continued to work closely with our partners, DKMS and Anthony Nolan, to ensure that the general public have the best engagement with us as possible whilst maintaining clarity that the information we share is specific to our partner agencies. We have continued to work alongside our partners in order to harness as much support as possible with the view and focus to recruit more diverse people onto donor registries. We strive to increase awareness in addition to our community engagement work by promoting what we do on social media and other supporting platforms and use effective case studies and these messages will be further strengthened by our website development.

In 2022/23, we recruited 1019 people to sign-up onto the donor register.

We envisage more work to be done with regards to our digital engagement and to increase awareness through online mediums. Over the last year, we have continued to share case studies of those affected by blood cancer in order to share real-life stories and keep the momentum going. We have seen an small increase in individuals holding their own ‘insupport of’ events in order to harness much needed funds for our work.

We have been developing relationships and growing our network within the industry. As a direct result of this work, the charity continues to be a member of the NBTA (National BAME Transplant Alliance) sub-committee on stem cell donation. This group, which consists of a number of charities as well as all four UK donor registries, expects to have a significant role in developing a national donor recruitment strategy for people from black, Asian, mixedheritage and minority ethnic communities over the next few years.

Fundraising

The landscape for fundraising remains to be a very challenging environment and some work has been undertaken to try and secure funding via the Trusts & Grants route by employing a freelance fundraiser for a limited amount of time. This individual has had to be placed on hold until we can secure further funds. There is a need for RABC to find other ways to be more sustainable moving forward.

We have also commenced work on the development for our website having received funding in 2022. Our vision is for our website to be used as a tool by which we can enhance our brand awareness and also for us to better capture donor data so that we can more effectively support our partners work. This work has been tendered out and we have successfully contracted this work to WebbedFeet developers (late 2023).

Collaboration and strategic impact

Through the NBTA and close collaboration with other small charities, we have seen the Aligned Registry (AN, DKMS, WBMDR and NHSBT) increase their ethnic minority donor targets and enhance their contractual alignment into 2023 and beyond. We have established an ongoing series of meetings with the Aligned Registry, with the goal of collaborating more closely, and taking more responsibility for ethnic minority recruitment.

Acknowledgements

The Trustees would like to thank the following individuals, companies and charitable trusts and organisations for their support throughout 2022/23:

Statement from Chair (Board of Trustees)

Off the back of the pandemic and disruption to our operations, 22/23 has been all about putting the right foundations in place, to enable the charity to continue its mission for many years to come. The return to in-person donor drives has been exciting and helped us generate important momentum, with us signing up over 1000 donors during this period.

In addition to the critical community engagement work that we're so passionate about, we've also made good progress via strategic collaboration with other charities, as part of the NBTA. This work is helping to ensure that there's a unified approach to donor recruitment on a national level, from those of us fighting tirelessly to reduce the inequality of blood cancer patients from an ethnic minority, who have a significantly lower chances of finding a lifesaving donor match. This collaborative approach has also built stronger relationships with the national registries, leading to them setting ethnic minority recruitment targets for the first time.

As we look ahead, we're very excited by the work we're doing to close the gap and believe we will continue to have an outsized impact with the team and partnerships that we have in place.

Race Against Blood Cancer

Charity No. 1162696

Company No. CE005053

Trustees' Report and Unaudited Accounts

31 March 2023

Race Against Blood Cancer Contents

Pages
Trustees' Annual Report 2
Independent Examiner's Report 3
Statement of Financial Activities 4
Summary Income and Expenditure Account 5
Balance Sheet 6
Statement of Cash flows 7
Notes to the Accounts 8 to 14
Detailed Statement of Financial Activities 15 to 16

Page 1

Race Against Blood Cancer Trustees Annual Report

The trustees, who are also directors of the charity for the purposes of the Companies Act 2006, present their report with the unaudited financial statements of the charity for the year ended 31 March 2023.

REFERENCE AND ADMINISTRATIVE DETAILS

Company No. CE005053

Charity No. 1162696

Registered Office

71-75 Shelton Street Covent Garden London WC2H 9JQ

Directors and Trustees

The Directors of the charitable company are its Trustees for the purposes of charity law. The following Directors and Trustees served during the year:

J. Bates G. Fiske D. Gardner M.M. Gardner J.I.B. Knox-Hooke H. Shah B. Westwood

Accountants

Solutions Accountancy & Bookkeeping Ltd 1 The Mews Little Brunswick Street Huddersfield HD1 5JL

The Trustees are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial position of the charity and to enable them to ensure that the financial statements comply with the Companies Act 2006. The Trustees are also responsible for safeguarding the assets of the charity and hence taking reasonable steps for the prevention and detection of fraud and other irregularities.

The above report has been prepared in accordance with the provisions applicable to companies subject to the small companies regime as set out in Part 15 of the Companies Act 2006 and in accordance with the Charities SORP (FRS 102).

Signed on behalf of the board

- Jacob Knox Hooke

J.I.B. Knox-Hooke Jacob Knox-Hooke (Mar 4, 2024 10:43 GMT) Trustee 29 February 2024

Page 2

Race Against Blood Cancer Independent Examiners Report

Independent Examiner's Report to the trustees of Race Against Blood Cancer

I report to the charity trustees on my examination of the financial statements of Race Against Blood Cancer for the year ended 31 March 2023.

Responsibilities and basis of report

As the charity's trustees of the company (and also its directors for the purposes of company law) you are responsible for the preparation of the financial statements in accordance with the requirements of the Companies Act 2006 ('the 2006 Act.

Having satisfied myself that the financial statements of the Charity are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity's financial statements as carried out under section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5) (b) of the 2011 Act.

Independent examiner's statement

I have completed my examination. I can confirm that no material matters have come to my attention in connection with the examination giving me cause to believe:

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the financial statements to be reached.

CPAA

Solutions Accountancy & Bookkeeping Ltd 1 The Mews Little Brunswick Street Huddersfield

HD1 5JL 29 February 2024

Page 3

Race Against Blood Cancer Statement of Financial Activities

for the year ended 31 March 2023

Notes
Income and endowments
from:
Donations and legacies
4
Other
5
Total
Expenditure on:
Raising funds
6
Other
7
Total
Net gains on investments
Net expenditure
8
Transfers between funds
Net expenditure before other
gains/(losses)
Other gains and losses
Net movement in funds
Reconciliation of funds:
Total funds brought forward
Total funds carried forward
Unrestricted
funds
2023
£
6,647
-
Restricted
funds
2023
£
-
18,525
Total funds
2023
£
6,647
18,525
Total funds
2022
£
12,505
9,412
6,647
795
6,021
18,525
-
43,240
25,172
795
49,261
21,917
1,209
25,410
6,816
-
43,240
-
50,056
-
26,619
-
(169)
-
(24,715)
-
(24,884)
-
(4,702)
-
(169) (24,715) (24,884) (4,702)
(169)
8,611
(24,715)
38,015
(24,884)
46,626
(4,702)
51,328
8,442 13,300 21,742 46,626

Page 4

Race Against Blood Cancer Summary Income and Expenditure Account

for the year ended 31 March 2023

Income
Gross income for the year
Expenditure
Interest payable
Total expenditure for the year
Net expenditure before tax for the year
Net expenditure for the year
2023
£
25,172
25,172
49,761
295
50,056
(24,884)
(24,884)
2022
£
21,917
21,917
26,392
227
26,619
(4,702)
(4,702)

Page 5

Race Against Blood Cancer Balance Sheet

at 31 March 2023

Company No.
CE005053
Notes
2023
£
Current assets
Cash at bank and in hand
32,725
32,725
Creditors:Amount falling due within one year
10
(3,980)
Net current assets
28,745
Total assets less current liabilities
28,745
Creditors:Amounts falling due after more than one year
11
(7,003)
Net assets excluding pension asset or liability
21,742
Total net assets
21,742
The funds of the charity
Restricted funds
12
Restricted income funds
13,300
13,300
Unrestricted funds
12
General funds
8,442
8,442
Reserves
12
Total funds
21,742
2022
£
60,219
60,219
(3,495)
56,724
56,724
(10,098)
46,626
46,626
38,015
38,015
8,611
8,611
46,626

These accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.

For the year ended 31 March 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

Approved by the board on 29 February 2024

And signed on its behalf by:

- Jacob Knox Hooke

Jacob Knox-Hooke (Mar 4, 2024 10:43 GMT)

J.I.B. Knox-Hooke

Trustee

29 February 2024

Page 6

Race Against Blood Cancer Statement of Cash flows for the year ended 31 March 2023

Cash flows from operating activities
Net expenditure per Statement of Financial Activities
Adjustments for:
Dividends, interest and rents from investments
Increase in trade and other payables
Net cash used in operating activities
Cash flows from investing activities
Dividends, interest and rents from investments
Net cash from investing activities
Cash flows from financing activities
Repayment of borrowings
Net cash used in financing activities
Net decrease in cash and cash equivalents
Cash and cash equivalents at the beginning of the year
Cash and cash equivalents at the end of the year
Components of cash and cash equivalents
Cash and bank balances
2023
£
(24,884)
(18,525)
290
(43,119)
18,525
18,525
(2,900)
(2,900)
(27,494)
60,219
32,725
32,725
32,725
2022
£
(4,702)
(9,412)
1,570
(12,544)
9,412
9,412
(1,902)
(1,902)
(5,034)
65,253
60,219
60,219
60,219

Page 7

Race Against Blood Cancer Notes to the Accounts

for the year ended 31 March 2023

Basis of preparation

The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2015) - (Charities SORP (FRS 102)), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.

Change in basis of accounting or to previous accounts

There has been no change to the accounting policies (valuation rules and method of accounting) since last year and no changes have been made to accounts for previous years.

Fund accounting

Income

Volunteer help The value of any volunteer help received is not included in the accounts. Investment income This is included in the accounts when receivable. Gains/(losses) on This includes any gain or loss resulting from revaluing investments to market value revaluation of fixed at the end of the year. assets Gains/(losses) on This includes any gain or loss on the sale of investments. investment assets

Page 8

Race Against Blood Cancer Notes to the Accounts

Expenditure

Taxation

The charity is exempt from corporation tax on its charitable activities.

Cash and cash equivalents

Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less and bank overdrafts. In the statement of financial position, bank overdrafts are shown within borrowings or current liabilities. In the Statement of Cash Flows, cash and cash equivalents are shown net of bank overdrafts that are repayable on demand and form an integral part of the company's cash management.

Trade and other creditors

Short term creditors are measured at the transaction price. Other creditors and provisions are recognised where the charity has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors and provisions are normally recognised at their settlement amount after allowing for any trade discounts due.

Pension costs

The charity operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the company pays fixed contributions into a separate entity. Once the contributions have been paid the company has no further payments obligations. The contributions are recognised as expenses when they fall due. Amounts not paid are shown in accruals in the balance sheet. The assets of the plan are held separately from the company in independently administered funds.

2 Company status

The company is a private company limited by guarantee and consequently does not have share capital.

Page 9

Race Against Blood Cancer Notes to the Accounts

3 Statement of Financial Activities - prior year

3
Statement of Financial Activities - prior year
Income and endowments from:
Donations and legacies
Other
Total
Expenditure on:
Raising funds
Other
Total
Net income
Net income before other
gains/(losses)
Other gains and losses:
Net movement in funds
Reconciliation of funds:
Total funds brought forward
Total funds carried forward
4
Income from donations and legacies
Donations From Events
General Donations
Regular Donations
5
Other income
Government JRS Grant
Other Grant Income
Unrestricted
funds
2022
£
12,505
9,412
21,917
1,209
25,410
26,619
(4,702)
(4,702)
(4,702)
13,313
8,611
Unrestricted
£
3,399
3,188
60
6,647
Restricted
£
-
18,525
18,525
Restricted
funds
2022
£
-
-
-
-
-
-
-
-
-
38,015
38,015
Total
2023
£
3,399
3,188
60
6,647
Total
2023
£
-
18,525
18,525
Total funds
2022
£
12,505
9,412
21,917
1,209
25,410
26,619
(4,702)
(4,702)
(4,702)
51,328
46,626
Total
2022
£
8,652
3,793
60
12,505
Total
2022
£
9,412
-
9,412

Page 10

Race Against Blood Cancer Notes to the Accounts

Costs of generating voluntary
income
Adhoc Donations MyDonate
Donations From Events
7
Other expenditure
Bank loan and overdraft
interest payable
Employee costs
General administrative costs
Legal and professional costs
8
Net expenditure before transfers
This is stated after charging:
Independent Examiner's fee
9
Staff costs
Salaries and wages
Social security costs
Pension costs
No employee received emoluments in excess
10 Creditors:
amounts falling due within one year
Bank loans and overdrafts
Other taxes and social security
Other creditors
Unrestricted
£
295
2,934
1,427
1,365
6,021
of £60,000.
Unrestricted
£
204
591
795
Restricted
£
-
43,240
-
-
43,240
2023
£
650
2023
45,273
-
901
46,174
2023
£
3,195
560
225
3,980
Total
2023
£
204
591
795
Total
2023
£
295
46,174
1,427
1,365
49,261
Total
2022
£
388
821
1,209
Total
2022
£
227
21,798
2,027
1,358
25,410
2022
£
650
2022
25,153
(3,873)
518
21,798
2022
£
3,000
495
-
3,495

Page 11

Race Against Blood Cancer Notes to the Accounts

11 Creditors:

amounts falling due after more than one year

Bank loans and overdrafts
12 Movement in funds
Restricted funds:
Restricted income funds:
Aylesford Family Trust
Roger Counter Foundation
W E Dunn Trust None
Albert Hunt Trust
Alex Duthie
Help Charity Shop
Christmas appeal
The People's Postcode Trust
and The National Lottery
Total
Unrestricted funds:
General funds
Total funds
At 1 April
2022
500
15,000
1,000
1,000
210
200
105
20,000
38,015
8,611
46,626
2023
£
7,003
7,003
Incoming
resources
(including
other
gains/losses
)
£
-
-
-
-
-
-
-
18,525
18,525
6,647
25,172
Resources
expended
£
(500)
(15,000)
(1,000)
(1,000)
(210)
(200)
(105)
(25,225)
(43,240)
(6,816)
(50,056)
2022
£
10,098
10,098
At 31
March
2023
£
-
-
-
-
-
-
-
13,300
13,300
8,442
21,742

Purposes and restrictions in relation to the funds:

Restricted funds: Aylesford Family Trust Roger Counter Foundation W E Dunn Trust None

Albert Hunt Trust Alex Duthie Help Charity Shop Christmas appeal

The People's Postcode Trust Made up of The People's Postcode Trust £2,500.00 and The National and The National Lottery Lottery £10,800.00

Page 12

Race Against Blood Cancer Notes to the Accounts

13 Analysis of net assets between funds

Net current assets
Creditors due in more than one year and
provisions
14 Reconciliation of net debt
Cash and cash equivalents
Bank loans
Net debt
Unrestricted
funds
£
26,245
(7,003)
19,242
At 1 April
2022
£
Restricted
funds
£
2,500
-
2,500
Cash flows
£
Total
£
28,745
(7,003)
21,742
At 31
March
2023
£
60,219 (27,494) 32,725
60,219
(13,098)
(13,098)
47,121
(27,494)
2,900
2,900
(24,594)
32,725
(10,198)
(10,198)
22,527
15 Commitments
Operating lease commitments
Annual commitments under non-cancellable operating leases
2023
Land and
buildings
£
Operating leases with expiry date:
Pension commitments
The pension cost charge to the company
amounted to:
are as follows:
2023
Other
£
2023
£
901
2022
Land and
buildings
£
2022
Other
£
2022
£
518

16 Related party disclosures

Controlling party

The company is limited by guarantee and has no share capital; thus no single party controls the company.

Page 13

Race Against Blood Cancer Detailed Statement of Financial Activities

for the year ended 31 March 2023

Income and endowments from:
Donations and legacies
Donations From Events
General Donations
Regular Donations
Other
Government JRS Grant
Other Grant Income
Total income and endowments
Expenditure on:
Costs of generating donations and
legacies
Adhoc Donations MyDonate
Donations From Events
Total of expenditure on raising
funds
Other expenditure
Bank loan and overdraft interest
payable
Employee costs
Salaries/wages
Employer's NIC
Pension costs
General administrative costs,
including depreciation and
amortisation
Equipment expensed
General insurances
Software, IT support and related
costs
Stationery and printing
Sundry expenses
Telephone, fax and broadband
Unrestricted
funds
2023
£
3,399
3,188
60
6,647
-
-
-
6,647
204
591
795
795
295
295
2,033
-
901
2,934
191
337
399
64
-
436
1,427
Restricted
funds
2023
£
-
-
-
-
-
18,525
18,525
18,525
-
-
-
-
-
-
43,240
-
-
43,240
-
-
-
-
-
-
-
Total funds
2023
£
3,399
3,188
60
6,647
-
18,525
18,525
25,172
204
591
795
795
295
295
45,273
-
901
46,174
191
337
399
64
-
436
1,427
Total funds
2022
£
8,652
3,793
60
12,505
9,412
-
9,412
21,917
388
821
1,209
1,209
227
227
25,153
(3,873)
518
21,798
-
324
360
139
886
318
2,027

Page 14

Race Against Blood Cancer Detailed Statement of Financial Activities

Race Against Blood Cancer
Detailed Statement of Financial Activities
Legal and professional costs
Accountancy and bookkeeping
Consultancy fees
Total of expenditure of other costs
Total expenditure
Net gains on investments
Net expenditure
Net expenditure before other
gains/(losses)
Other Gains
Net movement in funds
Reconciliation of funds:
Total funds brought forward
Total funds carried forward
765
600
1,365
6,021
6,816
-
(169)
(169)
-
(169)
8,611
8,442
-
-
-
43,240
43,240
-
(24,715)
(24,715)
-
(24,715)
38,015
13,300
765
600
1,365
49,261
50,056
-
(24,884)
(24,884)
-
(24,884)
46,626
21,742
830
528
1,358
25,410
26,619
-
(4,702)
(4,702)
-
(4,702)
51,328
46,626

Page 15